• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微纤溶酶的制备与纯化

Preparation and purification of microplasmin.

作者信息

Wu H L, Shi G Y, Bender M L

机构信息

Biochemistry Department, Medical College, National Cheng-Kung University, Taiwan, Republic of China.

出版信息

Proc Natl Acad Sci U S A. 1987 Dec;84(23):8292-5. doi: 10.1073/pnas.84.23.8292.

DOI:10.1073/pnas.84.23.8292
PMID:2960974
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC299528/
Abstract

A catalytically active, human microplasmin was produced by incubation of [Lys]plasmin in buffer at pH 11.0 for up to 12 hr. The microplasmin was purified by affinity chromatography that used lysine-Sepharose and soybean trypsin inhibitor-Sepharose columns. It is homogeneous and pure by electrophoretic analysis in NaDodSO4/polyacrylamide gels and by gel filtration on a Superose 12 column. The molecular weight of the microplasmin determined by NaDodSO4 gel electrophoresis is 29,000 and 26,500 under reducing condition, whereas the molecular weight of native plasmin is 76,500. Microplasmin consists mainly of the ligh (B) chain of native human plasmin and possesses one active site per protein molecule when titrated with p-nitrophenyl p'-guanidinobenzoate. Microplasmin hydrolyzes the peptide substrate NH2-D-Val-Leu-Lys-p-nitroanilide (S-2251) with a Km of 0.361 +/- 0.017 mM and a kcat of 40.3 +/- 3.3 s-1 at pH 7.4 and 37 degrees C, whereas native plasmin has a Km of 0.355 +/- 0.002 mM and a kcat of 27.9 +/- 0.3 s-1 under the same conditions.

摘要

通过在pH 11.0的缓冲液中孵育[赖氨酸]纤溶酶长达12小时,可产生具有催化活性的人微纤溶酶。微纤溶酶通过使用赖氨酸-琼脂糖和大豆胰蛋白酶抑制剂-琼脂糖柱的亲和色谱法进行纯化。通过在NaDodSO4/聚丙烯酰胺凝胶中的电泳分析以及在Superose 12柱上的凝胶过滤,它是均一且纯净的。在还原条件下,通过NaDodSO4凝胶电泳测定的微纤溶酶分子量为29,000和26,500,而天然纤溶酶的分子量为76,500。微纤溶酶主要由天然人纤溶酶的轻(B)链组成,在用对硝基苯基对'-胍基苯甲酸酯滴定法测定时,每个蛋白质分子具有一个活性位点。在pH 7.4和37℃条件下,微纤溶酶水解肽底物NH2-D-缬氨酸-亮氨酸-赖氨酸-对硝基苯胺(S-2251)的Km为0.361±0.017 mM,kcat为40.3±3.3 s-1,而在相同条件下天然纤溶酶的Km为0.355±0.002 mM,kcat为27.9±0.3 s-1。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1870/299528/239dfbe5a6d7/pnas00338-0129-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1870/299528/e61fbcdef3fc/pnas00338-0128-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1870/299528/239dfbe5a6d7/pnas00338-0129-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1870/299528/e61fbcdef3fc/pnas00338-0128-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1870/299528/239dfbe5a6d7/pnas00338-0129-a.jpg

相似文献

1
Preparation and purification of microplasmin.微纤溶酶的制备与纯化
Proc Natl Acad Sci U S A. 1987 Dec;84(23):8292-5. doi: 10.1073/pnas.84.23.8292.
2
Activation of human and bovine plasminogens by the microplasmin and streptokinase complex.微纤溶酶与链激酶复合物对人及牛纤溶酶原的激活作用。
Thromb Res. 1990 May 1;58(3):317-29. doi: 10.1016/0049-3848(90)90101-h.
3
Isolation and characterization of microplasminogen. A low molecular weight form of plasminogen.微纤溶酶原的分离与鉴定。一种低分子量形式的纤溶酶原。
J Biol Chem. 1988 Nov 15;263(32):17071-5.
4
[Hydrolysis of polymeric fibrin by plasmin, miniplasmin, microplasmin and trypsin].[纤溶酶、微型纤溶酶、微纤溶酶和胰蛋白酶对聚合纤维蛋白的水解作用]
Ukr Biokhim Zh (1978). 1992 May-Jun;64(3):14-20.
5
Differential vitreous dye diffusion following microplasmin or plasmin pre-treatment.微纤维蛋白溶解酶或纤维蛋白溶解酶预处理后玻璃体内染料扩散的差异。
Curr Eye Res. 2010 Mar;35(3):235-41. doi: 10.3109/02713680903484259.
6
Functional Kunitz inhibitor binding domain in plasmin-derived light chain as shown by affinity chromatography.亲和层析显示纤溶酶衍生轻链中的功能性库尼兹抑制剂结合域。
Int J Pept Protein Res. 1986 Jul;28(1):85-90. doi: 10.1111/j.1399-3011.1986.tb03232.x.
7
Fibrinolysis with des-kringle derivatives of plasmin and its modulation by plasma protease inhibitors.纤溶酶去kringle结构域衍生物的纤维蛋白溶解作用及其受血浆蛋白酶抑制剂的调节
Biochemistry. 1998 Jun 23;37(25):9112-8. doi: 10.1021/bi980180d.
8
Partial purification and characterization of a new fast-acting plasmin inhibitor from human platelets. Evidence for non-identity with the known plasma proteinase inhibitors.人血小板中一种新型快速作用纤溶酶抑制剂的部分纯化及特性鉴定。与已知血浆蛋白酶抑制剂不同的证据。
Biochem J. 1980 Apr 1;187(1):173-80. doi: 10.1042/bj1870173.
9
Identification of plasmin as the major contaminant in immunoglobulin preparations.鉴定纤溶酶为免疫球蛋白制剂中的主要污染物。
Comp Biochem Physiol B. 1986;84(4):507-11. doi: 10.1016/0305-0491(86)90114-8.
10
[Isolation of fibronectin peptide fragments of various sizes and biological activity using affinity chromatography on an immobilized plasmin].利用固定化纤溶酶亲和色谱法分离不同大小和生物活性的纤连蛋白肽片段
Vopr Med Khim. 1989 Nov-Dec;35(6):103-5.

引用本文的文献

1
Site-specific PEGylation of micro-plasmin for improved thrombolytic therapy through engineering enhanced resistance against serpin mediated inhibition.通过工程改造增强对丝氨酸蛋白酶抑制剂介导抑制的抗性,实现微纤溶酶的位点特异性聚乙二醇化,以改善溶栓治疗。
PLoS One. 2019 May 29;14(5):e0217234. doi: 10.1371/journal.pone.0217234. eCollection 2019.
2
Generation and characterization of tissue-type plasminogen activator transgenic rats.组织型纤溶酶原激活物转基因大鼠的构建与鉴定。
J Thromb Thrombolysis. 2018 Jan;45(1):77-87. doi: 10.1007/s11239-017-1582-1.
3
Amorphous protein aggregates stimulate plasminogen activation, leading to release of cytotoxic fragments that are clients for extracellular chaperones.

本文引用的文献

1
Ageing of alpha-chymotrypsin: Cannibalistic and hydroxide ion reactions.α-糜蛋白酶的老化:自噬和氢氧根离子反应。
Proc Natl Acad Sci U S A. 1981 Jul;78(7):4116-7. doi: 10.1073/pnas.78.7.4116.
2
The denaturation of trypsin.胰蛋白酶的变性
Biochem Biophys Res Commun. 1982 Jul 30;107(2):742-5. doi: 10.1016/0006-291x(82)91553-4.
3
Activation of human neo-plasminogen-Val442 by urokinase and streptokinase and a kinetic characterization of neoplasmin-Val442.尿激酶和链激酶对人新型纤溶酶原-Val442的激活作用以及新型纤溶酶-Val442的动力学特征
无定形蛋白质聚集体刺激纤溶酶原激活,导致细胞毒性片段释放,这些片段是细胞外伴侣蛋白的作用对象。
J Biol Chem. 2017 Sep 1;292(35):14425-14437. doi: 10.1074/jbc.M117.786657. Epub 2017 Jul 14.
4
Novel Thrombolytic Drug Based on Thrombin Cleavable Microplasminogen Coupled to a Single-Chain Antibody Specific for Activated GPIIb/IIIa.基于凝血酶可裂解微纤溶酶原与活化的糖蛋白IIb/IIIa特异性单链抗体偶联的新型溶栓药物。
J Am Heart Assoc. 2017 Feb 3;6(2):e004535. doi: 10.1161/JAHA.116.004535.
5
In vitro fibrinolysis and antithrombosis characterizations of novel recombinant microplasminogen with RGD and GPRP peptides.新型含RGD和GPRP肽的重组微纤溶酶原的体外纤维蛋白溶解和抗血栓形成特性
J Thromb Thrombolysis. 2016 Jul;42(1):118-26. doi: 10.1007/s11239-016-1334-7.
6
High-level expression, purification, and enzymatic characterization of truncated human plasminogen (Lys531-Asn791) in the methylotrophic yeast Pichia pastoris.截短型人纤溶酶原(Lys531 - Asn791)在甲基营养型酵母毕赤酵母中的高水平表达、纯化及酶学特性分析
BMC Biotechnol. 2015 Jun 9;15:50. doi: 10.1186/s12896-015-0179-z.
7
Profile of ocriplasmin and its potential in the treatment of vitreomacular adhesion.奥克纤溶酶简介及其在治疗玻璃体黄斑黏附中的潜力。
Clin Ophthalmol. 2014 May 6;8:847-56. doi: 10.2147/OPTH.S32274. eCollection 2014.
8
Characterization of a reduced form of plasma plasminogen as the precursor for angiostatin formation.鉴定血纤维蛋白溶酶原的一种还原形式作为生成血管抑素的前体。
J Biol Chem. 2014 Jan 31;289(5):2992-3000. doi: 10.1074/jbc.M113.539924. Epub 2013 Dec 12.
9
Ocriplasmin for vitreoretinal diseases.用于玻璃体视网膜疾病的奥克纤溶酶
J Biomed Biotechnol. 2012;2012:354979. doi: 10.1155/2012/354979. Epub 2012 Oct 14.
10
Proteolytic resistance conferred to fibrinogen by von Willebrand factor.von Willebrand 因子赋予纤维蛋白原的抗蛋白水解作用。
Thromb Haemost. 2010 Feb;103(2):291-8. doi: 10.1160/TH09-07-0420. Epub 2009 Dec 18.
J Biol Chem. 1980 Jun 10;255(11):5329-35.
4
Plasminogen: purification from human plasma by affinity chromatography.纤溶酶原:通过亲和色谱法从人血浆中纯化。
Science. 1970 Dec 4;170(3962):1095-6. doi: 10.1126/science.170.3962.1095.
5
Cleavage of structural proteins during the assembly of the head of bacteriophage T4.在噬菌体T4头部组装过程中结构蛋白的切割
Nature. 1970 Aug 15;227(5259):680-5. doi: 10.1038/227680a0.
6
Isolation of plasmin-free human plasminogen with N-terminal glutamic acid.分离具有N端谷氨酸的无纤溶酶人纤溶酶原。
Biochim Biophys Acta. 1971 Nov 13;250(2):447-51. doi: 10.1016/0005-2744(71)90202-6.
7
Measurement of the binding of antifibrinolytic amino acids to various plasminogens.抗纤溶氨基酸与各种纤溶酶原结合的测定。
Arch Biochem Biophys. 1972 Jul;151(1):194-9. doi: 10.1016/0003-9861(72)90488-2.
8
The primary structure of human plasminogen. II. The histidine loop of human plasmin: light (B) chain active center histidine sequence.人纤溶酶原的一级结构。II. 人纤溶酶的组氨酸环:轻链(B链)活性中心组氨酸序列。
J Biol Chem. 1973 Mar 10;248(5):1631-3.
9
Release of an N-terminal peptide from human plasminogen during activation with urokinase.在尿激酶激活过程中,人纤溶酶原N端肽段的释放。
Biochim Biophys Acta. 1973 Jan 25;295(1):381-4. doi: 10.1016/0005-2795(73)90106-2.
10
Studies on the active center of human plasmin. Partial amino acid sequence of a peptide containing the active center serine residue.人纤溶酶活性中心的研究。含活性中心丝氨酸残基的肽段的部分氨基酸序列。
J Biol Chem. 1969 Jul 10;244(13):3590-7.